Computerized Cardiotocography and Maternal Coffee Habits

The study includes pregnant women referred for foetal antepartum computerized cardiotocography (cCTG) monitoring as outpatients. Pregnant women were divided into two groups based on their coffee intake: the coffee group and the control group. Each pregnant woman had cCTG. Two doctors assessed and recorded the amount of coffee taken by pregnant women before the CTG.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prenatal Care

Age range

18 year–50 year

Sex eligibility

Female

Study type

Observational

Primary location

Università degli studi della Campania "Luigi Vanvitelli"- OB & Gyn -

Naples, Italia, 80138, Italy

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

gestationale age >37 weeks

Exclusion criteria

fetal malformations,
stillbirths
preterm labour
preterm and term premature rupture of membranes

Treatment and study plan

Primary outcomes

Computerized cardiotocography

Time frame: 1 day (cardiotocographic's test)

Computerized cardiotocography (cCTG) parameters evaluate the fetal heart rate. We analyzed the cCTG between the two groups: pregnant who took coffee and pregnant with no coffee intake.

Sponsors and collaborators

Lead sponsor

University of Campania Luigi Vanvitelli

Other

Registry information

Official study title

Computerized Cardiotocography and Fetal Heart Response to Maternal Coffee Intake: A Prospective Study

Important dates

Study start: 2022
Primary completion: 2022
Study completion: 2022
First posted: Oct 4, 2022
Registry last updated: Oct 4, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed